Save time and get answers to complex questions with AI chat
Novartis patent term dabrafenib?Lipitor vs generics what's the price gap?Patent tenofovir alafenamide gilead?When does guselkumab patent expire?Prolia and osteonecrosis?
See the DrugPatentWatch profile for qelbree
Qelbree (viloxazine) was first approved by the U.S. Food and Drug Administration on December 28, 2020. It became available for prescription in the United States shortly thereafter. The drug was later approved in Canada in late 2021.
Other Questions About Qelbree :